Image courtesy of Orfit Industries
October 19, 2015 — Orfit Industries introduced and demonstrated its HP Pro Solution, an innovative, comprehensive and versatile immobilization system for proton therapy, at the American Society for Radiation Oncology (ASTRO) 57th annual meeting. The technology, designed for brain, head and neck treatments, has received U.S. Food and Drug Administration (FDA) 510(k) clearance.
When used with Orfit’s ultra-thin and stable Nanor immobilization masks, based on nanotechnology, HP Pro offers a unique combination of high-precision immobilization and patient comfort.
The British Royal Infirmary in Bristol, United Kingdom, has recently introduced a new gamma knife treatment using the Orfit radiotherapy mask. The treatment has been welcomed by specialists as a non-invasive, potential life-saver, helping to kill off unwanted growths of brain tumors with one millimeter precision, without harming healthy brain tissue.
The HP Pro hardware is designed for use in both proton and photon therapy. The products are homogenous, low density, lightweight and available in a range of configurations including overlays, extensions and a combination overlay/extension in one product. A full range of accessories, including patient-customized head rests, is available.
For more information: www.orfit.com
March 28, 2024 
